Preparing for a crisis is not a luxury; it is a necessity. Constant cyber-attacks, the COVID-19 pandemic, and regulatory requirements have proven this. You know the odds are high that your company will suffer, or has experienced, a disaster or crisis. You cannot say you weren't ready; today's extreme public and government scrutiny demand that you should have been prepared. MIT's Crisis Management & Business Resiliency course will help prepare you for the inevitable.
Transform your organization's engineering capabilities with comprehensive AI implementation spanning the complete design-to-deployment pipeline, from LLM-driven parametric design through advanced manufacturing optimization, computer vision quality control, and real-world deployment strategies. In this intensive hands-on course, you'll join accomplished global peers to master deployable AI workflows, create neural surrogates for expensive simulations, implement MLOps practices with regulatory compliance, and build complete integrated systems using open-source tools – leaving with working template libraries and custom components ready for immediate organizational deployment.
Assess the critical elements of the real estate development process from start to finish through the lens of an investor. In this accelerated three-day course, you’ll join a wide range of global professionals from the real estate, banking, finance/investment, and insurance industries to master frameworks for assessing, managing, and pricing risk in real estate development—and acquire proven strategies for determining whether to move forward with a project.
Brian Anthony
Lead Instructor
Participating Instructor
Brian Anthony is the co-director of MIT’s Medical Electronic Device Realization Center and associate director of MIT.nano. With over 25 years of experience in product realization, Brian Anthony designs instruments and techniques to monitor and control physical systems. His work involves systems analysis and design, calling upon mechanical, electrical, and optical engineering, along with computer science and optimization.
Morris Z. Rosenberg
Dr. Morris Rosenberg is founder and a consultant at MRosenberg BioPharma Consulting. He has over 25 years experience in the development of therapeutic agents to treat a variety of human diseases.
J. Christopher Love
J. Christopher Love is the Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering. He is also an Associate Member of the Broad Institute, and an Associate Member at the Ragon Institute of MGH, MIT, and Harvard. Following completion of his doctoral studies, he extended his research into immunology at Harvard Medical School with Hidde Ploegh from 2004-2005, and at the Immune Disease Institute from 2005-2007.
James C. Leung
Dr. James C. Leung is a Senior Research Fellow at the MIT Center for Biomedical Innovation (CBI).
Robert D. Kiss
Dr. Robert D. Kiss is a Distinguished Engineer and Senior Director of BioProcess Development at Genentech. His areas of focus within the industry have included media/process optimization and product quality control (especially protein glycosylation), barriers to virus contamination of mammalian cultures, and scale-up/scale-down strategies.
Neal Connors
Dr. Neal Connors is the founder and a consultant at Phoenix BioConsulting, LLC. His industrial microbiology experience is diverse: bioprocess development for renewable chemicals, fermentation and strain improvement for the production of anti-bacterial and anti-fungal natural products (e.g. Cancidas®), heterologous protein production using microbial fermentation or mammalian cell culture, whole-cell biocatalysis for the production of chiral intermediates.
Kristala L. Jones Prather
Kristala Jones Prather is the Arthur D. Little Professor of Chemical Engineering at MIT and an investigator in the multi-institutional Synthetic Biology Engineering Research Center (SynBERC) funded by the National Science Foundation (USA). Professor Prather has co-authored more than 75 manuscripts and two book chapters, and has five issued patents with several additional applications pending.